Kaléo is a fully integrated pharmaceutical company dedicated to inventing, manufacturing, and commercializing medical countermeasures for the U.S. military and our allies. Kaléo’s innovative auto-injection technologies are protected by an extensive intellectual property portfolio of more than 200 issued patents as well as being the first to meet the U.S. Food and Drug Administration (FDA) draft guidance standard for 99.999% device reliability.